Get the app!
Back to Companies

Cartesian Therapeutics, Inc.

RNACNasdaqCIK: 0001453687

Cartesian Therapeutics, Inc. (RNAC) shows 12 recent insider filings from 10 insiders, with 1 buying and 3 selling. With $205.8K in purchases and $258.7K in sales, the recent tape is a roughly balanced mix of buying and selling (net sales of $52.9K). Seymour June Ann (Chief Accounting Officer) is the most active by dollar volume, and the single largest transaction was $442.5K by Seymour June Ann. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$1.1M
Purchases
$205.8K
Sales
$258.7K
Unique Insiders
10

Recent Insider Trades

12 loaded
Apr 6RNAC
Cartesian Therapeutics, Inc.
Hoge Elizabeth10% OwnerExercise$0
Apr 6RNAC
Cartesian Therapeutics, Inc.
Kalayoglu Murat10% OwnerExercise$0
Jan 8RNAC
Cartesian Therapeutics, Inc.
Davis BlaineChief Financial OfficerSell$72.2K
Jan 8RNAC
Cartesian Therapeutics, Inc.
Miljkovic MilosChief Medical OfficerSell$24.4K
Jan 8RNAC
Cartesian Therapeutics, Inc.
Brunn CarstenPresident and CEO, DirectorSell$162.1K
Jan 2RNAC
Cartesian Therapeutics, Inc.
English EmilyChief Operations OfficerExercise$49.5K
Dec 18RNAC
Cartesian Therapeutics, Inc.
Bot Adrian IonDirectorGrant$142.6K
Dec 18RNAC
Cartesian Therapeutics, Inc.
Bot Adrian IonDirectorOther$0
Dec 8RNAC
Cartesian Therapeutics, Inc.
BARABE TIMOTHY CDirectorBuy$205.8K
Nov 19RNAC
Cartesian Therapeutics, Inc.
Singer MichaelDirectorGift$0
Oct 28RNAC
Cartesian Therapeutics, Inc.
Seymour June AnnChief Accounting OfficerAward$442.5K
Oct 28RNAC
Cartesian Therapeutics, Inc.
Seymour June AnnChief Accounting OfficerOther$0

12 filings